Safety and Efficacy of Monthly Long-acting IM Injection of 25mg or 40 mg GA Depot in Subjects With PPMS

Clinical trial NCT03362294 · TERMINATED

Trial details

NCT number: NCT03362294
Sponsor: Mapi Pharma Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Progressive Multiple Sclerosis

Start date: 2017-12-11
Primary completion: 2025-06-20
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.